INTERNATIONAL PATENT: ASGARD THERAPEUTICS AB FILES APPLICATION FOR "RNA-BASED STRATEGIES FOR DENDRITIC CELL REPROGRAMMING AND USES THEREOF"

GENEVA, June 16 -- ASGARD THERAPEUTICS AB (Medicon Village223 81 Lund) filed a patent application (PCT/EP2024/084945) for "RNA-BASED STRATEGIES FOR DENDRITIC CELL REPROGRAMMING AND USES THEREOF" on Dec 05, 2024. With publication no. WO/2025/120097, the details related to the patent application was published on Jun 12, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ROSA, Fabio Alexandre Fiuza (Rua do Brejo ndegree53Touria, Pousos2410-205 Leiria), ARH, Nejc (Dobovičnikova ulica 141360 Vrhnika), VAZ, Beatriz Lourenco (Rua João Pereira Caldas, ndegree8304950 Cambeses - Moncão, Vi...